Universal-Beteiligungs- und Servicegesellschaft’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.7M Buy
99,726
+39,047
+64% +$1.18M 0.01% 1051
2026
Q1
$2.05M Buy
60,679
+119
+0.2% +$3.37K ﹤0.01% 1234
2025
Q4
$1.65M Sell
60,560
-10,653
-15% -$374K ﹤0.01% 1325
2025
Q3
$2.86M Buy
71,213
+15,929
+29% +$599K ﹤0.01% 1124
2025
Q2
$1.84M Buy
55,284
+633
+1% +$19.2K ﹤0.01% 1276
2025
Q1
$1.6M Buy
+54,651
New +$1.81M ﹤0.01% 1304

Other funds holding AGIO

Universal-Beteiligungs- und Servicegesellschaft's AGIO Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Agios Pharmaceuticals (AGIO) stake by 64% in Q2 2026, buying an estimated $1.18M and bringing the position to 99,726 shares worth $3.7M. The position accounts for 0.01% of the portfolio, ranked #1051.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in AGIO in Q1 2025 and has held it in 6 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 99,726 shares of Agios Pharmaceuticals worth $3.7M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 39,047 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.18M.
  • Agios Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1051 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Agios Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.